期刊文献+

三种补钙方法在预防外周血造血干细胞采集中枸橼酸盐中毒的效果比较 被引量:6

The comparison of the effectiveness on three methods of calcium supplementation for preventing citrate intoxication during peripheral blood stem cell harvesting
原文传递
导出
摘要 目的 探讨最佳的补钙方法以预防外周血造血干细胞(PBSC)采集中的枸橼酸盐中毒(CI).方法 对141例自体患者或异体供者进行了166例次的PBSC采集,按补钙方法不同将患/供者随机分为三组,即口服组(66例次):采集中每小时服1次10%葡萄糖注射液20 ml+10%葡萄糖酸钙20 ml,整个过程口服3~4次;静注组(52例次):采集中每小时静脉缓慢注射1次10%葡萄糖注射液20 ml+10%葡萄糖酸钙10 ml,整个采集过程应用3~4次;静滴组(50例次):采集中静脉持续滴注10%葡萄糖注射液350 ml+10%葡萄糖酸钙30 ml,速度为25~30滴/min,出现CI症状时稍加快滴速.采集中密切观察并记录CI发生情况.结果 口服组CI发生率为28.1%,其中轻度12例次,中度6例次,无重度中毒者,出现CI的平均时间为开始采集后122 min;静注组CI的发生率为18.2%,其中轻度7例次,中度1例次,无重度中毒者,出现CI的平均时间为开始采集后134 min;静滴组CI的发生率为10.0%,均为轻度中毒者,出现CI的平均时间为开始采集后172 min.三组间的CI发生率(χ2=6.612,P<0.05)及CI程度(χ2=7.290,P<0.05)的分布比较差异均有统计学意义,其中以静滴组CI的发生率最低、程度最轻,而CI发生时间差异无统计学意义(χ2=1.427,P>0.05).结论 静脉滴注葡萄糖酸钙是预防造血干细胞采集中枸橼酸盐中毒的最佳方法,其疗效佳和安全性好,值得临床推广应用. Objective To study the best method of calcium supplementation for preventing citrate intoxication(CI)during peripheral blood stem cell(PBSC)harvesting.Methods According to the different methods of administration of calcium gluconate, 166 procedures of PBSC harvesting in 141 patients/donors were randomly divided into three groups - group oral administration, group intravenous injection and group intravenous drip.In group oral administration(n = 66), 10% calcium gluconate 20 ml in 10% GS 20 ml was administrated by oral one time per hour during harvesting.When symptoms of CI appeared, extra administration was given.In group intravenous injection(n = 52), 10% calcium gluconate 10 ml in 10% GS 20 ml was administrated for intravenous injection per hour during harvesting.When symptoms of CI appeared, extra administration was given.In group intravenous drip(n =50), 10% calcium gluconate 30 ml in 10% GS 350 ml was administrated for intravenous drip at the speed of 25 - 30 drops per minute during harvesting.When symptoms of CI appeared, accelerate the intravenous drip.Symptoms of CI were observed and recorded during harvesting.Results The incidences of CI in three groups were 28.1% , 18.2% and 10.0% in which 12 were mild degree and 6 were moderate degree in group oral administration, 7 were mild degree and 1 was moderate degree in group intravenous injection and all 5 were mild degree in group intravenous drip.The mean time of starting symptoms of CI in group oral administration, group intravenous injection and group intravenous drip were 122 minutes, 134 minutes and 172 minutes.There were statistical differences of the incidence(χ2 =6.612, P <0.05= and the degrees(χ2=7.290, P <0.05)of CI among three groups.Both the incidence and degree of CI was the lowest and lightest in group intravenous drip among the three groups.There was no statistical difference of the mean time of starting CI among the three groups(χ2= 1.427, P > 0.05).Conclusions Intravenous drip of calcium gluconate is the best and safe method for effectively preventing the CI during PBSC harvesting.
出处 《中国实用医刊》 2010年第7期5-7,共4页 Chinese Journal of Practical Medicine
关键词 外周血造血干细胞 采集 枸橼酸盐中毒 补钙 Peripheral blood stem cell Harvesting/collection Citrate intoxication Calcium supplementation
  • 相关文献

同被引文献44

  • 1谢润兰,龙正美.自体外周血造血干细胞采集术的护理体会[J].贵州医药,2011,35(3):286-287. 被引量:2
  • 2鲍立,黄晓军,刘开彦,许兰平,陈欢,张耀臣,陈育红,韩伟,陆道培.ABO血型不合对异基因造血干细胞移植的影响[J].北京大学学报(医学版),2005,37(2):126-129. 被引量:14
  • 3谢桂岚,李志祥,李哲先.外周血干细胞采集时机及其相关因素的探讨[J].中华内科杂志,2005,44(6):450-451. 被引量:13
  • 4Gratwohl A,Baldomero H,Horisberger B,et al.Current trends in hematopoietic stem cell transplantation in Europe.Blood.2002; 100(7):2374-2386.
  • 5Stem Cell Trialists' Collaborative Group.Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies:an individual patient data meta-analysis of nine randomized trials.J Clin Oncol.2005; 23(22):5074-5087.
  • 6Gratwohl A,Baldomero H,Schmid O,et al.Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe:a report of the EBMT activity survey 2003.Bone Marrow Transplant.2005;36(7):575-590.
  • 7Gratwohl A,Baldomero H,Schwendener A,et al.The EBMT activity survey 2007 with focus on allogeneic HSCT for AML and novel cellular therapies.Bone Marrow Transplant.2009;43(4):275-291.
  • 8Rowley SD,Liang PS,Ulz L.Transplantation of ABO-incompatible bone marrow and peripheral blood stem cell components.Bone Marrow Transplant.2000;26(7):749-757.
  • 9Rowley SD.Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs.Bone Marrow Transplant.2001;28(4):315-321.
  • 10Stussi G,Muntwyler J,Passweg JR,et al.Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.Bone Marrow Transplant.2002;30(2):87-93.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部